US firms take issue at FDA product labelling requirement
This article was originally published in Clinica
Executive Summary
The requirement that nearly all devices bear the manufacturer's name is shaping up as one of the most unpopular provisions of last year's device user fee bill, otherwise abbreviated as MDUFMA.